|
1
|
Ossovskaya V, Wang Y, Budoff A, Xu Q,
Lituev A, Potapova O, Vansant G, Monforte J and Daraselia N:
Exploring molecular pathways of triple-negative breast cancer.
Genes Cancer. 2:870–879. 2011. View Article : Google Scholar
|
|
2
|
Metzger-Filho O, Tutt A, de Azambuja E,
Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis
P, et al: Dissecting the heterogeneity of triple-negative breast
cancer. J Clin Oncol. 30:1879–1887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu H, Scholz C, Zang C, Schefe JH, Habbel
P, Regierer AC, Schulz CO, Possinger K and Eucker J: Metformin and
the mTOR inhibitor everolimus (RAD001) sensitize breast cancer
cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Anticancer Res. 32:1627–1637. 2012.PubMed/NCBI
|
|
4
|
Stebbing J and Ellis P: An overview of
drug development for metastatic breast cancer. Br J Nurs.
21:S18–S22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brouckaert O, Wildiers H, Floris G and
Neven P: Update on triple-negative breast cancer: Prognosis and
management strategies. Int J Womens Health. 4:511–520.
2012.PubMed/NCBI
|
|
6
|
Laugsch M, Seebach J, Schnittler H and
Jessberger R: Imbalance of SMC1 and SMC3 cohesins causes specific
and distinct effects. PLoS One. 8:e651492013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Z, Scannell DR, Eisen MB and Tjian R:
Control of embryonic stem cell lineage commitment by core promoter
factor, TAF3. Cell. 146:720–731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rhodes JM, McEwan M and Horsfield JA: Gene
regulation by cohesin in cancer: Is the ring an unexpected party to
proliferation? Mol Cancer Res. 9:1587–1607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nasmyth K and Haering CH: The structure
and function of SMC and Kleisin complexes. Annu Rev Biochem.
74:595–648. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY
and Qin J: SMC1 is a downstream effector in the ATM/NBS1 branch of
the human S-phase checkpoint. Genes Dev. 16:571–582. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michaelis C, Ciosk R and Nasmyth K:
Cohesins: Chromosomal proteins that prevent premature separation of
sister chromatids. Cell. 91:35–45. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirano T: At the heart of the chromosome:
SMC proteins in action. Nat Rev Mol Cell Biol. 7:311–322. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rocquain J, Gelsi-Boyer V, Adélaïde J,
Murati A, Carbuccia N, Vey N, Birnbaum D, Mozziconacci MJ and
Chaffanet M: Alteration of cohesin genes in myeloid diseases. Am J
Hematol. 85:717–719. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamamoto G, Irie T, Aida T, Nagoshi Y,
Tsuchiya R and Tachikawa T: Correlation of invasion and metastasis
of cancer cells, and expression of the RAD21 gene in oral squamous
cell carcinoma. Virchows Arch. 448:435–441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yadav S, Sehrawat A, Eroglu Z, Somlo G,
Hickey R, Yadav S, Liu X, Awasthi YC and Awasthi S: Role of SMC1 in
overcoming drug resistance in triple negative breast cancer. PLoS
One. 8:e643382013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naiche LA, Harrelson Z, Kelly RG and
Papaioannou VE: T-box genes in vertebrate development. Annu Rev
Genet. 39:219–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Showell C, Binder O and Conlon FL: T-box
genes in early embryo genesis. Dev Dyn. 229:201–218. 2004.
View Article : Google Scholar
|
|
18
|
Kilic N, Feldhaus S, Kilic E, Tennstedt P,
Wicklein D, Wasielewski R, Viebahn C, Kreipe H and Schumacher U:
Brachyury expression predicts poor prognosis at early stages of
colorectal cancer. Eur J Cancer. 47:1080–1085. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang XR, Ng D, Alcorta DA, Liebsch NJ,
Sheridan E, Li S, Goldstein AM, Parry DM and Kelley MJ: T
(brachyury) gene duplication confers major susceptibility to
familial chordoma. Nat Genet. 41:1176–1178. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du R, Wu S, Lv X, Fang H, Wu S and Kang J:
Overexpression of brachyury contributes to tumor metastasis by
inducing epithelial-mesenchymal transition in hepatocellular
carcinoma. J Exp Clin Cancer Res. 33:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang B, Cohen JR, Fernando RI, Hamilton
DH, Litzinger MT, Hodge JW and Palena C: The embryonic
transcription factor Brachyury blocks cell cycle progression and
mediates tumor resistance to conventional antitumor therapies. Cell
Death Dis. 4:e6822013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mese nchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Savagner P: Leaving the neighborhood:
Molecular mechanisms involved during epithelial-mesenchymal
transition. BioEssays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin Invest.
119:1417–1419. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imajyo I, Sugiura T, Kobayashi Y, Shimoda
M, Ishii K, Akimoto N, Yoshihama N, Kobayashi I and Mori Y: T-box
transcription factor Brachyury expression is correlated with
epithelial-mesenchymal transition and lymph node metastasis in oral
squamous cell carcinoma. Int J Oncol. 41:1985–1995. 2012.PubMed/NCBI
|
|
30
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: Insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fernando RI, Litzinger M, Trono P,
Hamilton DH, Schlom J and Palena C: The T-box transcription factor
Brachyury promotes epithelial-mesenchymal transition in human tumor
cells. J Clin Invest. 120:533–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu K, Liu B and Liu Y: Impact of Brachyury
on epithelial-mesenchymal transitions and chemosensitivity in
non-small cell lung cancer. Mol Med Rep. 12:995–1001.
2015.PubMed/NCBI
|
